Abstract
In initial staging of head and neck cancers, the addition of FDG PET to conventional imaging improves the accuracy for cervical nodal metastases. The sensitivity of FDG PET is, however, limited in nodes <1 cm and in completely necrotic nodes. In the posttherapy setting, PET scans obtained at least 10 weeks after radiotherapy have an excellent predictive value to rule out residual disease. Due to the limited positive predictive value of FDG PET after radiation therapy, a positive PET scan needs to be confirmed before management decisions are made.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jemal, A., Siegel, R., Ward, E., et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58, 71–96.
Lindholm, P., Minn, H., Leskinen-Kallio, S., Bergman, J., Ruotsalainen, U., Joensuu, H. (1993) Influence of the blood glucose concentration on FDG uptake in cancer – a PET study. J Nucl Med 34, 1–6.
Yeung, H.W., Grewal, R.K., Gonen, M., Schoder, H., Larson, S.M. (2003) Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 44, 1789–96.
Garcia, C.A., Van Nostrand, D., Atkins, F., et al. (2006) Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol 8, 24–9.
Brink, I., Klenzner, T., Krause, T., et al. (2002) Lymph node staging in extracranial head and neck cancer with FDG PET – appropriate uptake period and size-dependence of the results. Nuklearmedizin 41, 108–13.
Graham, M.M., Menda, Y. (2005) Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas. Semin Nucl Med 35, 220–52.
Greene F., Fleming, I.D. (2002) AJCC (American Joint Committee on Cancer) Cancer Staging Manual 6th edn, Springer-Verlag, New York.
Robbins, K.T., Clayman, G., Levine, P.A., et al. (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128, 751–8.
Di Martino, E., Nowak, B., Krombach, G.A., et al. (2000) Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET). Laryngorhinootologie 79, 201–6.
Hannah, A., Scott, A.M., Tochon-Danguy, H., et al. (2002) Evaluation of 18 F- fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 236, 208–17.
Kresnik, E., Mikosch, P., Gallowitsch, H.J., et al. (2001) Evaluation of head and neck cancer with 18 F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 28, 816–21.
Stuckensen, T., Kovacs, A.F., Adams, S., Baum, R.P. (2000) Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28, 319–24.
Civantos, F.J., Gomez, C., Duque, C., et al. (2003) Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 25, 1–9.
Hyde, N.C., Prvulovich, E., Newman, L., Waddington, W.A., Visvikis, D., Ell, P. (2003) A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39, 350–60.
Stoeckli, S.J., Steinert, H., Pfaltz, M., Schmid, S. (2002) Is there a role for positron mission tomography with 18 F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24, 345–9.
Schoder, H., Carlson, D.L., Kraus, D.H., et al. (2006) 18 F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47, 755–62.
Kim, S.Y., Roh, J.L., Yeo, N.K., et al. (2007) Combined 18 F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol 18, 1698–703.
Goerres, G.W., Schmid, D.T., Gratz, K.W., von Schulthess, G.K., Eyrich, G.K. (2003) Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 39, 547–51.
Schwartz, D.L., Rajendran, J., Yueh, B., et al. (2003) Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 129, 1173–8.
Sigg, M.B., Steinert, H., Gratz, K., Hugenin, P., Stoeckli, S., Eyrich, G.K., et al. (2003) Staging of head and neck tumors: [18 F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities. J Oral Maxillofac Surg 61, 1022–9.
Teknos, T.N., Rosenthal, E.L., Lee, D., Taylor, R., Marn, C.S. (2001) Positron emission tomography in the evaluation of stage III and IV head and neck cancer Head Neck 23, 1056–60.
Mendenhall, W.M., Mancuso, A.A., Parsons, J.T., Stringer, S.P., Cassisi, N.J. (1998) Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 20, 739–44.
Mendenhall, W.M., Mancuso, A.A., Amdur, R.J., Stringer, S.P., Villaret, D.B., Cassisi, N.J. (2001) Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site. Am J Otolaryngol 22, 261–7.
Rusthoven, K.E., Koshy, M., Paulino, A.C. (2004) The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 101, 2641–9.
Fogarty, G.B., Peters, L.J., Stewart, J., Scott, C., Rischin, D., Hicks, R.J. (2003) The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 25, 138–45.
Greven, K.M., Keyes, J.W., Jr., Williams, D.W., III, McGuirt, W.F., Joyce, W.T., III. (1999) Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer 86, 114–8.
Johansen, J., Eigtved, A., Buchwald, C., Theilgaard, S.A., Hansen, H.S. (2002) Implication of 18 F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 112, 2009–14.
Jungehulsing, M., Scheidhauer, K., Damm, M., et al. (2000) 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 123, 294–301.
Kole, A.C., Nieweg, O.E., Pruim, J., et al. (1998) Detection of unknown occult primary tumors using positron emission tomography. Cancer 82, 1160–6.
Wong, W.L., Saunders, M. (2003) The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 15, 461–6.
Goodwin, W.J., Jr. (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means. Laryngoscope 110, 1–18.
Klabbers, B.M., Lammertsma, A.A., Slotman, B.J. (2003) The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Mol Imaging Biol 5, 257–70.
Isles, M.G., McConkey, C., Mehanna, H.M. (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33, 210–22.
Yao, M., Smith, R.B., Hoffman, H.T., et al. (2009) Clinical significance of postradiotherapy [18 F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer – a long-term outcome report. Int J Radiat Oncol Biol Phys 74, 9–14.
Greven, K.M., Williams, D.W., III, McGuirt, W.F., Sr., et al. (2001) Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23, 942–6.
Yao, M., Smith, R.B., Graham, M.M., et al. (2005) The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 63, 991–9.
Porceddu, S.V., Jarmolowski, E., Hicks, R.J., et al. (2005) Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27, 175–81.
Kutler, D.I., Patel, S.G., Shah, J.P. (2004) The role of neck dissection following definitive chemoradiation. Oncology (Williston Park) 18, 993–8; discussion 999, 1003–4, 1007.
Rogers, J.W., Greven, K.M., McGuirt, W.F., et al. (2004) Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy. Int J Radiat Oncol Biol Phys 58, 694–7.
Schoder, H., Yeung, H.W. (2004) Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 34, 180–97.
Terhaard, C.H., Bongers, V., van Rijk, P.P., Hordijk, G.J. (2001) F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 23, 933–41.
Allal, A.S., Slosman, D.O., Kebdani, T., Allaoua, M., Lehmann, W., Dulguerov, P. (2004) Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18 F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59, 1295–300.
Ciernik, I.F., Dizendorf, E., Baumert, B.G., et al. (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 57, 853–63.
Paulino, A.C., Koshy, M., Howell, R., Schuster, D., Davis, L.W. (2005) Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61, 1385–92.
Heron, D.E., Andrade, R.S., Flickinger, J., et al. (2004) Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report. Int J Radiat Oncol Biol Phys 60, 1419–24.
Dietl, B., Marienhagen, J., Kuhnel, T., Schreyer, A., Kolbl, O. (2008) The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist’s perspective. Oral Oncol 44, 504–8.
Paulino, A.C., Johnstone, P.A. (2004) FDG-PET in radiotherapy treatment planning: Pandora’s box. Int J Radiat Oncol Biol Phys 59, 4–5.
Scarfone, C., Lavely, W.C., Cmelak, A.J., et al. (2004) Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45, 543–52.
Wang, D., Schultz, C.J., Jursinic, P.A., et al. (2006) Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65, 143–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Humana Press
About this protocol
Cite this protocol
Menda, Y., Graham, M.M. (2011). FDG PET Imaging of Head and Neck Cancers. In: Juweid, M., Hoekstra, O. (eds) Positron Emission Tomography. Methods in Molecular Biology, vol 727. Humana Press. https://doi.org/10.1007/978-1-61779-062-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-61779-062-1_2
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-061-4
Online ISBN: 978-1-61779-062-1
eBook Packages: Springer Protocols